SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
16.31
+0.35 (2.19%)
Nov 13, 2026, 4:00 PM EST - Market closed
SkinHealth Systems Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 288.56 | 300.79 | 334.29 | 397.99 | 365.88 | 260.09 |
Revenue Growth | -4.42% | -10.02% | -16.00% | 8.78% | 40.67% | 118.39% |
Gross Profit Gross Profit Growth | 193.96 | 196.36 | 190.3 | 155.11 | 248.78 | 178.54 |
Operating Income Operating Income Growth | 6.91 | -20.8 | -59.77 | -130.92 | -25.84 | -39.93 |
Net Income Net Income Growth | -18.29 | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Earnings Per Share EPS Growth | -2.84 | -3.26 | -7.27 | -15.21 | -4.59 | -74.20 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Americas Americas Growth | 200.83 | 203.98 | 216.99 | 227.71 | 243.24 | 169.43 |
Europe, the Middle East and Africa Europe, the Middle East and Africa Growth | 61.67 | 68.3 | 71.63 | 88.09 | 68.33 | 46.96 |
Asia Pacific (APAC) Asia Pacific (APAC) Growth | 26.06 | 28.52 | 45.67 | 82.19 | 54.31 | 43.7 |
Total Total Growth | 288.56 | 300.79 | 334.29 | 397.99 | 365.88 | 260.09 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 112.39 | 230.67 | 368.06 | 523.03 | 568.2 | 901.89 |
Total Debt Total Debt Growth | 264.24 | 378.76 | 568.16 | 752.29 | 753.61 | 748.56 |
Net Cash (Debt) Net Cash Growth | -151.85 | -148.08 | -200.1 | -229.26 | -185.41 | 153.33 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -23.59 | -21.81 | -28.08 | -34.82 | -24.97 | 30.03 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 23.58 | 37.49 | 16.13 | 21.75 | -106.6 | -28.36 |
Capital Expenditures CapEx Growth | -0.88 | -0.3 | -0.76 | -22.28 | -12.32 | -11.2 |
Free Cash Flow Free Cash Flow Growth | 22.69 | 37.18 | 15.38 | -0.53 | -118.92 | -39.56 |
Free Cash Flow Growth | -41.09% | 141.79% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 67.22% | 65.28% | 56.93% | 38.97% | 68.00% | 68.65% |
Operating Margin | 2.40% | -6.92% | -17.88% | -32.89% | -7.06% | -15.35% |
Pretax Margin | -4.57% | -1.97% | -8.84% | -25.60% | 12.39% | -146.35% |
Profit Margin | -6.34% | -3.16% | -8.70% | -25.16% | 12.09% | -145.63% |
FCF Margin | 7.86% | 12.36% | 4.60% | -0.13% | -32.50% | -15.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 27.21 | - |
Forward PE | 7.38 | 9.12 | 42.50 | 16.31 | 47.05 | 260.64 |
P/FCF Ratio | 4.70 | 4.77 | 12.83 | - | - | - |
PS Ratio | 0.37 | 0.59 | 0.59 | 1.03 | 3.29 | 13.90 |